42
Views
10
CrossRef citations to date
0
Altmetric
Post Graduate Course on Liver metastasis

Liver Resection for Noncolorectal, Nonneuroendocrine Metastases

, , , , &
Pages 458-462 | Published online: 14 Mar 2016

References

  • Rivadeneira D., Daly J. Hepatic metastases. In: Karakousi C. (ed.). Surgical Oncology. Contemporary principles and practice. New York: Mc Graw Hill, 2001, pp. 1133–48.
  • Elias D., Cavalcanti A., Sabourin J. C. et al. Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases. J Surg Oncol, 1998, 69: 88–93.
  • Fong Y., Cohen A. M., Fortner J. C. et al. Liver resection for colorectal metastases. J Clin Oncol, 1997, 15: 938–46.
  • Dousset B., Saint-Marc O., Pitre J. et al. Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation. World J Surg, 1996, 20: 908–25.
  • Jaeck D., Oussoultzoglou E., Bachellier P. et al. Hepatic meta-stases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery. World J Surg, 2001, 25: 689–92.
  • Lang H., Oldhafer K. J., Weimann A. et al. Liver transplantation for metastatic neuroendocrine tumors. Ann Surg, 1997, 225: 34754.
  • Le Treut Y. P., Sebag F., Hardwigsen J. Surgery of liver metastases of non-colorectal origin. An Chir, 1998, 52: 88–91.
  • Hamy A., Mirallie E., Bizouarn P. et al. Hepatic resections for non-colorectal, non-neuroendocrine metastases. Results of 32 hepatectomies in 27 patients. Ann Chir, 2000, 125: 124–30.
  • Berney T., Mentha G., Roth A. D., Morel P. Results of surgical resection of liver metastases from non-colorectal primaries. Br J Surg, 1998, 85: 1423–7.
  • Wolf R. F., Goodnight J. E., Krag D. E., Schneider P. D. Results of resection and proposed guidelines for patient selection in instances of non-colorectal metastases. Surg Gynecol Obstet, 1991, 173: 454–60.
  • Elias D., Cavalcanti de Albuquerque A., Eggenspieler P. et al. Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg, 1998, 187: 487–93.
  • Hamy A. P., Paineau J. R., Mirallie E. C. et al. Hepatic resections for non-colorectal metastases: forty resections in 35 patients. Hepatogastroenterology, 2000, 47: 1090–4.
  • Harrison L. E., Brennan M. F., Newman E. et al. Hepatic resection for noncolorectal metastases: a fifteen-year experience with ninety-six patients. Surgery, 1997, 121: 625–32.
  • Hemming A. W., Sielaff T. D., Gallinger S. et al. Hepatic resection for noncolorectal, nonneuroendocrine metastases. Liver Transpl, 2000, 6: 97–101.
  • Laurent C., Rullier E., Feyler A. et al. Resection of noncolorec-tal and nonneuroendocrine liver metastases: late metastases are the only chance of cure. World J Surg, 2001, 25: 1532–6.
  • Yamada H., Katoh H., Kondo S. et al. Hepatectomy for metastases from non-colorectal and non-neuroendocrine tumor. Anticancer Res, 2001, 21: 4159–62.
  • van Ruth S., Mutsaerts E., Zoetmulder F. A., van Coevorden F. Metastasectomy for liver metastases of non-colorectal primaries. Eur J Surg Oncol, 2001, 27: 662–7.
  • Karavias D. D., Tepetes K., Karatzas T. et al. Liver resection for metastatic non-colorectal non-neuroendocrine hepatic neoplasms. Eur J Surg Oncol, 2002, 28: 135–9.
  • Bennett B. C., Selby R., Bahnson R. R. Surgical resection for management of renal cancer with hepatic involvement. J Urol, 1995, 154: 972–4.
  • Forster J. H. Surgical treatment for metastatic liver tumors. Hepatogastroenterology, 1990, 37: 182.
  • Schwartz S. I. Hepatic resection for nonolorectal nonneuroendo-crine metastases. World J Surg, 1995, 19: 72–5.
  • Williams R. N., White S. A., Lloyd D. M. Two-stage subtotal hepatectomy for metastatic adrenal adenocarcinoma, a case report. Hepatogastroenterology, 2002, 49: 535–7.
  • Trivedi U. H., Poston G. J., Singh M. P. Ten-year survival following resection of an adrenal neuroblastoma with multiple liver metastases. Br J Clin Pract, 1990, 44: 702–4.
  • Chi D. S., Fong Y., Venkatraman E. S., Barakat R. R. Hepatic resection for metastatic gynecologic carcinoma. Gynecol Oncol, 1997, 66: 45–51.
  • Goulet R. J. Jr, Hardacre J. M., Einhorn L. H. et al. Hepatic resection for disseminated germ cell carcinoma. Ann Surg, 1992, 212: 290–3.
  • Singer S., Demetri G. D., Baldini E. H., Fletcher C. D. Management of soft-tissue sarcomas: an overview and update. Lancet Oncol, 2000, 1: 75–85.
  • Lang H., Nussbaum K. T., Kaudel P. et al. Hepatic metastases from leiomyosarcoma: a single-center experience with 34 liver resections during a 15-year period. Ann Surg, 2000, 231: 500–5.
  • DeMatteo R. P., Shah A., Fong Y. et al. Results of hepatic resection for sarcoma metastatic to liver. Ann Surg, 2001, 234: 5407.
  • Ng E. H., Pollock R. E., Munsell M. F. et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg, 1992, 215: 68–77.
  • Ng E. H., Pollock R. E., Romsdahl M. M. Prognostic implications of patterns of failure for gastrointestinal leiomyosarcoma. Cancer, 1992, 69: 1334–41.
  • Kohno H., Nagasue N., Araki S., Kato T. Ten-year survival after synchronous resection of liver metastasis from intestinal leiomyo-sarcoma. Cancer, 1981, 47: 1421–3.
  • Joensuu H., Fletcher C., Dimitrijevic S. et al. Management of malignant gastrointestinal stromal tumours. Lancet Oncol, 2002, 3: 655–4.
  • DeMatteo R. P. The GIST of targeted cancer therapy: a tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571). Ann Surg Oncol, 2002, 9: 831–9.
  • Demetri G. D., von Mehren M., Blanke C. D. et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med, 2002, 347: 472–80.
  • Joensuu H., Roberts P. J., Sarlomo-Rikala M. et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med, 2001, 344: 1052–6.
  • Selzner M., Morse M., Vredenburgh J. et al. Liver metastases from breast cancer: long-term survival after curative resection. Surgery, 2000, 127: 383–9.
  • O’Reilly S. M., Richards M. A., Rubens R. D. Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival. Eur J Cancer, 1990, 26: 574–7.
  • Patanaphan V., Salazar O. M., Risco R. Breast cancer: metastatic patterns and their prognosis. South Med J, 1988, 81: 1109–12.
  • Elias D., Lasser P., Spielmann M. et al. Surgical and chemo-therapeutic treatment of hepatic metastases from carcinoma of the breast. Surg Gynecol Obstet, 1991, 172: 461–4.
  • Seifert J. K., Weigel T. F., Gonner U. et al. Liver resection for breast cancer metastases. Hepatogastroenterology, 1999, 46: 2935–40.
  • Elias D., Lasser P., Montrucolli D. et al. Hepatectomy for liver metastases from breast cancer. Eur J Surg Oncol, 1995, 21: 5103.
  • Pocard M., Falcou M. C., Salmon R. J. On the prognosis criteria for hepatic resection in cases of breast metastasis. Surgery, 2001, 129: 651–2.
  • Raab R., Nussbaum K. T., Behrend M., Weimann A. Liver meta-stases of breast cancer, results of liver resection. Anticancer Res, 1998, 18: 2231–3.
  • Maksan S., Lehnert T., Bastert G., Herfarth C. Curative liver resection for metastatic breast cancer. Eur J Surg Oncol, 2000, 26: 209–12.
  • Pocard M., Pouillart P., Asselain B., Salmon R. Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol, 2000, 26: 155–9.
  • Rose D., Essner R., Hughes T. et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg, 2001, 136: 950–5.
  • Bedikian A. Y., Legha S. S., Mavligit G. et al. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognosis factors. Cancer, 1995, 76: 1665–70.
  • Aoyama T., Mastrangelo M., Berd D. et al. Protracted survival after resection of metastatic uveal melanoma. Cancer, 2000, 89: 1561–8.
  • Fujii K., Fujioka S., Kato K. et al. Resection of liver metastasis from gastric adenocarcinoma. Hepatogastroenterology, 2001, 48: 368–71.
  • Zacherl J., Zacherl M., Scheuba C. et al. Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg, 2002, 6: 682–9.
  • Ochiai T., Sasako M., Mizuno S. et al. Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg, 1994, 1175–8.
  • Saito A., Korenaga D., Sakaguchi Y. et al. Surgical treatment for gastric carcinomas with concomitant hepatic metastasis. Hepato-gastroenterology, 1996, 43: 560–4.
  • Miyazaki M., Itoh H., Nakagawa K. et al. Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol, 1997, 92: 490–3.
  • Ambiru S., Miyazaki M., Itoh H. et al. Benefits and limits of hepatic resection for gastric metastases. Am J Surg, 2001, 181: 279–83.
  • Bines S., England G., Deziel D. et al. Synchronous, metachronous, and multiple hepatic resections of liver tumors originating from primary gastric tumors. Surgery, 1993, 114: 799–805.
  • Okano K., Macha T., Ishimura K. et al. Hepatic resection for metastatic tumors from gastric cancer. Ann Surg, 2002, 235: 8691.
  • Adam R. Les indications d’exerese des metastases hepatiques non colo-rectales non neuroendocrines. In: «XXXIII Journees de Chirurgie Hepato-Bilaires».Paris, 2001, pp. 28–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.